Find a TenderAwarded without competition
Published 18 Jan 2023, 10:35 GMT

Official UK procurement notice

Pandemic Resilience, Supply & R&D Agreement for mRNA vaccines

Official notice

Authority: Department of Health & Social Care (Central government)

GoodsAward procedure without prior publication of a call for competition
Budget not disclosedValue not published
Awarded 20 Dec 2022no call for competition
Awarded to MODERNA BIOTECH UK LIMITED

What is being bought

Published requirement description

The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. The objective of security of supply in such circumstances is to be met by the construction of a mRNA manufacturing facility sited within the UK which will work alongside UK-based fill/finish providers to supply vaccines. In addition, the contract also includes certain commitments for the supplier to invest in R&D in the field of mRNA vaccines and therapeutics within the UK.

CPV: Design and execution of research and development · Vaccines

The lotProcurement structure

single lot · no lot value published
Lot #1The contract is to establish UK-based mRNA vaccine development and manufacturing…Awarded

The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. Additional information: Contract value is being withheld due to commercial sensitivity (Reg 50(6)(b) and (c)). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:<br/><br/>(i) the supplier in its negotiations with other national governments

Delivery: UK

Procedure terms & legal framework

From the official record
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
18 Jan 2023, 10:35 GMT
Last source update
18 Jan 2023, 10:35 GMT
FTS notice number
2023/S 000-001501
Classification (CPV)
Design and execution of research and developmentVaccines
Delivery area
UK
Official registry OCID
ocds-h6vhtk-039868 Find a Tender
Why no open competition
The procurement falls outside the scope of application of the directive
Published justification

The contract has been awarded under the exclusion in Regulation 15 (Defence and security) of the Public Contracts Regulations 2015. The contract is for protection of the essential security interests and resilience of future United Kingdom pandemic preparedness. The award follows the Authority's press announcement in June 2022 (www.gov.uk/government/news/mode… ↗) that it had entered into an agreement in principle with Moderna for the strategic partnership. The Authority is not obliged under the UK public procurement regulations to follow a statutory procurement process because Regulation 15(2)(a) (essential security interests of the UK) of the PCR 2015 applies. This notice is therefore being published on a voluntary basis. Nothing in this notice, nor in its publication, implies any intention or gives rise to an obligation to enter into a statutory procurement process under the UK public procurement regulations.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Bids received 1
Contracts signed 1latest 20 Dec 2022
Awarded toValueDateStatus
MODERNA BIOTECH UK LIMITEDSME——Awarded

Contracts

Bid statistics published by the authority

BidsSMEVCSEValid bid range
1bids——£1 – £1

Contracting authority & participating public bodies

Department of Health and Social Care

Contracting authorityCentral GovernmentMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 39 Victoria Street, London, London, SW1H 0EUContact name, email

Dispute resolution & review bodies

  • The High CourtReview body London

Bidders & participating suppliers

1 commercial party on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.